Insulin Dependent Gestational Diabetes Mellitus: Randomized Trial of Induction of Labour at 38 and 40 Weeks of Gestation
Not Applicable
Completed
- Conditions
- Gestational Diabetes Mellitus
- Registration Number
- NCT01256892
- Lead Sponsor
- Medical University of Vienna
- Brief Summary
To evaluate the impact of induction of labour at 38 weeks with the induction of labour at 40 weeks in women with insulin dependent gestational diabetes mellitus on maternal and fetal outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- pregnant women with insulin dependent gestational diabetes mellitus
Exclusion Criteria
- chronic inflammatory disease,
- autoimmune disease,
- pre-existing diabetes mellitus,
- previous cesarean section,
- multiple pregnancies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link insulin resistance in gestational diabetes to maternal-fetal outcomes when labor is induced at 38 vs. 40 weeks?
How does early labor induction (38 weeks) compare to standard care (40 weeks) in managing hyperglycemia-related complications in insulin-dependent GDM?
Which biomarkers (e.g., HbA1c, placental growth factor) predict optimal timing for labor induction in women with severe gestational diabetes?
What are the potential adverse events of labor induction at 38 weeks in insulin-dependent GDM, and how do they contrast with delayed induction risks?
How do combination therapies like metformin and early induction affect neonatal hypoglycemia rates compared to insulin alone in GDM management?